DATASHEET
Host:
Rabbit
Target Protein:
LCAT
Immunogen Range:
151-250/440
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
3931
Swiss Prot:
P04180
Source:
KLH conjugated synthetic peptide derived from human LCAT
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Background:
Central enzyme in the extracellular metabolism of plasma lipoproteins. Synthesized mainly in the liver and secreted into plasma where it converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lysophosphatidylcholines on the surface of high and low density lipoproteins (HDLs and LDLs). The cholesterol ester is then transported back to the liver. Has a preference for plasma 16:0-18:2 or 18:O-18:2 phosphatidylcholines. Also produced in the brain by primary astrocytes, and esterifies free cholesterol on nascent APOE-containing lipoproteins secreted from glia and influences cerebral spinal fluid (CSF) APOE- and APOA1 levels. Together with APOE and the cholesterol transporter ABCA1, plays a key role in the maturation of glial-derived, nascent lipoproteins. Required for remodeling high-density lipoprotein particles into their spherical forms.
VALIDATION IMAGES
Formalin-fixed and paraffin embedded rat brain labeled with Anti LCAT Polyclonal Antibody, Unconjugated (bs-1972R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
K562 lysates probed with LCAT Polyclonal Antibody, Unconjugated (bs-1972R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Mouse brain lysates probed with LCAT Polyclonal Antibody, Unconjugated (bs-1972R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Lane 1: Liver lysates probed with LCAT Polyclonal Antibody, Unconjugated (bs-1972R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.